Image

Global Lung Stent Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Lung Stent Market, By Type (Tracheobronchial Stents, Laryngeal Stents), Material (Metal Stents, Silicone Stents, Hybrid Stents), Product (Self-Expandable Stents, Non-Expandable Stents), End User (Hospitals, Ambulatory Surgery Centers) – Industry Trends and Forecast to 2029.

Lung Stent Market

Global Lung Stent Market Analysis and Size

Minimally invasive surgical procedures is widely gaining attraction especially in the developing economies. And using stents facilitates the success of a minimally invasive surgical procedure. The stents are manufactured using an array of materials and are scientifically proven to be safe during a surgical procedure.

  • Data Bridge Market Research analyses that the lung stent market is expected to undergo a CAGR of 6.40% during the forecast period. This indicates that the market value, which was USD 98.49 million in 2021, would rocket up to USD 161.78 million by 2029. “Metal Stents” dominates the material segment of the lung stent market owing to the growing awareness about the advantages associated with metal stents, such as ease of insertion, thinner walls as compared to silicone lung stents, and ability to adapt to the twisted airway. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Lung Stent Market Definition

From the name itself, it is clear that lung stent are the medical products that are used to open wide the clogged or blocked blood vessels during a surgical procedure. Stents are dissolvable in nature and its deployment doesn’t have any side effect on the body. Stents are important for the surgeons as they facilitate a greater and clearer view of the surgical site.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD million, Volumes in Units, Pricing in USD

Segments Covered

Type (Tracheobronchial Stents, Laryngeal Stents),  Material (Metal Stents, Silicone Stents, Hybrid Stents), Product (Self-Expandable Stents, Non-Expandable Stents), End User (Hospitals, Ambulatory Surgery Centers)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Thermo Fisher Scientific Inc. (US), Novartis AG (Switzerland), Abbott (US), Amgen Inc. (US), Johnson & Johnson Services, Inc. (US), GlaxoSmithKline plc (UK), Bayer AG (Germany), BD (US), Boston Scientific Corporation (US), Taewoong Medical Co., Ltd. (South Korea), Micro-Tech (Nanjing) Co., Ltd. (China), Novatech SA (France), E. Benson Hood Laboratories, Inc. (US), Merit Medical Systems, Inc. (US), Cook (US), EFER ENDOSCOPY (France), ENDO-FLEX GmbH (Germany), Standard Sci. Tech Inc. (South Korea), and Stening SRL (Argentina)    

Market Opportunities

  • Growth in the awareness about the benefits of maintaining personal health
  • Increasing incidence rate of lung cancer   
  • Rising research and development opportunities

Lung Stent Market Dynamics

Drivers

  • Rising prevalence of cancer

Growing incidence rate of cancer and respiratory disorders globally is one of the major factors fostering the growth of the market. Lung cancer is the leading cause of deaths worldwide. More than 1 million cases per year are witnessed in India and this condition may prevail for lifetime if not treated properly.    

  • Research and development proficiencies

Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted for the advancements in medical technologies and devices is also bolstering the market growth rate.

  • Growing investment for healthcare facilities

Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.  

Opportunities

Furthermore, upsurge in the public-private funding for target research activities, increasing consumption of smoking products, growing air pollution level and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2022 to 2029. Additionally, unhealthy lifestyle of individuals, rising internet penetration rate, rising geriatric population base,  increasing need of 3D printing of lung stents along with rising development of biodegradable and drug eluting lung stent product development and commercialization and increasing per capita expenditure on health care will further expand the market's growth rate in the future. 

Restraints/Challenges Global Lung Stent Market

On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities, uneven distribution of medical services, dearth of skilled medical professionals, and dearth of awareness in the backward economies are expected to obstruct market growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, emergence of alternative technologies, rising complications associated with the stents, limited insurance coverage and regulatory compliance, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2022-2029.

This lung stent market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the lung stent market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Lung Stent Market

The COVID-19 pandemic essentially affected the market. This is because of the fact that majority of the healthcare resources were directed towards meeting the demand arising out of COVID-19 patients. Postponement of non-elective surgeries and non-essential healthcare procedures has further derailed the market growth rate in this pandemic period. Further, restrictions imposed on travel owing to the lockdown regulations further challenged the market growth rate in this period. However, the post pandemic period will help to generate profits and revenues.

Recent Development

  • In January 2020, the U.S. FDA approved 3D printed airway stent which is made to fit the patient’s airway. This study was conducted by Cleveland Clinic and it is estimated that around 30,000 stents will be implanted by the end of 2020 in the U.S. alone. This shows the potential demand for lung stents in the near future.

Global Lung Stent Market Scope

The lung stent market is segmented on the basis of product, type, material and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Tracheobronchial Stents
  • Laryngeal Stents

Based on type, lung stent market is segmented into tracheobronchial stents and laryngeal stents.

Material

  • Metal Stents
  • Silicone Stents
  • Hybrid Stents

On the basis of material, lung stent market is segmented into metal stents, silicone stents and hybrid stents. Metal stents have been further segmented into nitinol stents, stainless steel stents and other metal stents.

Product

  • Self-Expandable Stents
  • Non-Expandable Stents

Based on product, lung stent market is segmented into self-expandable stents and non-expandable stents.

End user

  • Hospitals
  • Ambulatory Surgery Centers

Lung stent market has also been segmented based on the end user into hospitals and ambulatory surgery centers.

Lung Stent Market Regional Analysis/Insights

The lung stent market is analysed and market size insights and trends are provided by country, product, type, material and end user as referenced above.

The countries covered in the lung stent market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the lung stent market because of the strong base of healthcare facilities, widespread utilization of medications, increasing occurrence of lifestyle diseases, increasing consciousness regarding the essence of maintaining good health and rising number of research activities in this region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, increasing occurrence of lifestyle diseases, large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The lung stent market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for lung stent market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the lung stent market. The data is available for historic period 2010-2020.

Competitive Landscape and Lung Stent Market Share Analysis

The lung stent market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to lung stent market.

Some of the major players operating in the lung stent market are:

  • Thermo Fisher Scientific Inc. (US)
  • Novartis AG (Switzerland)
  • Abbott (US)
  • Amgen Inc. (US)
  • Johnson & Johnson Services, Inc. (US)
  • GlaxoSmithKline plc (UK)
  • Bayer AG (Germany)
  • BD (US)
  • Boston Scientific Corporation (US)
  • Taewoong Medical Co., Ltd. (South Korea)
  • Micro-Tech (Nanjing) Co., Ltd. (China)
  • Novatech SA (France)
  • E. Benson Hood Laboratories, Inc. (US)
  • Merit Medical Systems, Inc. (US)
  • Cook (US)
  • EFER ENDOSCOPY (France)
  • ENDO-FLEX GmbH (Germany)
  • Standard Sci. Tech Inc. (South Korea)
  • Stening SRL (Argentina)    

Research Methodology : Global Lung Stent Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-lung-stent-market


SKU-

Why Choose Us


Frequently Asked Questions

The Lung Stent Market Value is expected USD 161.78 million by 2029.
The Lung Stent Market is Projected to Grow at a CAGR of 6.40% During the Forecast Period of 2022 to 2029.
Thermo Fisher Scientific Inc. (US), Novartis AG (Switzerland), Abbott (US), Amgen Inc. (US), Johnson & Johnson Services, Inc. (US), GlaxoSmithKline plc (UK), Bayer AG (Germany), BD (US), Boston Scientific Corporation (US), Taewoong Medical Co., Ltd. (South Korea), Micro-Tech (Nanjing) Co., Ltd. (China), Novatech SA (France), E. Benson Hood Laboratories, Inc. (US), Merit Medical Systems, Inc. (US), Cook (US), EFER ENDOSCOPY (France), ENDO-FLEX GmbH (Germany), Standard Sci. Tech Inc. (South Korea), and Stening SRL (Argentina) are the Major Companies Operating in Lung Stent Market.
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The Lung Stent Market Report Curated by the Data Bridge Market Research Team Includes In-Depth Expert Analysis, Patient Epidemiology, Pipeline Analysis, Pricing Analysis, and Regulatory Framework.